Friday, November 04, 2022 12:02:41 PM
The growth potential is huge. Their Year end report showed 485% growth Y/Y and they have 2023 income expected to be exponentially more than that. Their business model is primarily SaaS where they earn $40-$80per patient on the service on a monthly subscription basis. They are paid by doctors who get paid by Medicare, medicaid and private insurance to track and monitor people with chronic health conditions in their homes dramatically decreasing the overall medical costs by preventing hospitalization and incidents. Profit margins projected at 75% gross sales.
There are not a lot of clear 10 bagger stocks out there but this is one you need to put on your list. Long holds can expect the company to be bought out within 2 years. Expected and announced for 2023, excess cashflow will be used for share buybacks and they will up list to the nasdaq. Based on their sales trajectory, they will be over 1B market cap by the end of 2023 with a modest PE ratio.
Recent RQHTF News
- Another Day, Another Healthcare Stock Finding Success • AllPennyStocks.com • 12/13/2023 06:40:00 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM